Peritoneal dialysis should not be the first choice for renal replacement therapy in the elderly.
Based on our review, it appears fair to infer that substantive differences in long-term outcome with PD compared with in-center HD have not been documented. PD may offer a slight advantage in younger, nondiabetic patients in the early phase of renal replacement therapy. Nevertheless, PD is not an advantageous option for that large cohort of the dialysis population in the United States comprised of elderly patients with diabetes.
Renal Disease Division, State University of New York, Downstate Medical Center, Brooklyn, New York 11203, USA.
Mary
M
Mallappallil
Ankita
A
Patel
Eli A
EA
Friedman
D006801:Humans; D007676:Kidney Failure, Chronic / Q000628:therapy*; D010530:Peritoneal Dialysis